Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

THOMAS THOMSEN AUTORISERET FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.6% 7.9% 7.5% 9.0% 8.5% 6.8% 10.7% 10.7%   Credit score (0-100)   37 31 31 27 28 35 23 23   Credit rating   BBB BB BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -60.8 -68.1 -79.1 -58.5 -63.5 -89.1 0.0 0.0   EBITDA   -733 -813 -851 -843 -855 -848 0.0 0.0   EBIT   -803 -883 -921 -913 -925 -951 0.0 0.0   Pre-tax profit (PTP)   237.6 146.8 111.7 79.4 99.8 139.2 0.0 0.0   Net earnings   183.8 113.4 85.7 61.2 77.0 108.3 0.0 0.0   Pre-tax profit without non-rec. items   238 147 112 79.4 99.8 139 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 359 0.0 0.0   Shareholders equity total   721 779 808 812 771 757 542 542   Interest-bearing liabilities   144 0.0 0.0 38.5 49.6 297 0.0 0.0   Balance sheet total (assets)   1,202 1,171 1,088 1,082 1,106 1,376 542 542   Net Debt   144 -103 -7.0 38.5 49.6 267 -52.2 -52.2     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -60.8 -68.1 -79.1 -58.5 -63.5 -89.1 0.0 0.0   Gross profit growth   33.7% -12.1% -16.1% 26.1% -8.6% -40.4% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,202 1,171 1,088 1,082 1,106 1,376 542 542   Balance sheet change%   6.0% -2.6% -7.1% -0.5% 2.2% 24.5% -60.6% 0.0%   Added value   -733.5 -812.7 -851.2 -843.2 -855.0 -848.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -140 -140 -140 -140 -140 186 -359 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1,322.2% 1,295.5% 1,164.4% 1,562.2% 1,457.8% 1,067.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.1% 13.1% 10.4% 7.9% 9.8% 12.6% 0.0% 0.0%   ROI %   24.8% 15.6% 12.3% 8.8% 11.1% 14.7% 0.0% 0.0%   ROE %   28.0% 15.1% 10.8% 7.6% 9.7% 14.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   59.9% 66.5% 74.3% 75.0% 69.7% 55.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -19.6% 12.6% 0.8% -4.6% -5.8% -31.5% 0.0% 0.0%   Gearing %   19.9% 0.0% 0.0% 4.7% 6.4% 39.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.4% 12.7% 0.0% 33.7% 18.0% 9.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0   Current Ratio   0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0   Cash and cash equivalent   0.0 102.5 7.0 0.0 0.0 29.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   120.1 107.1 92.3 124.9 120.8 86.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -298.6 -121.7 -115.4 -125.0 -207.0 -212.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -733 -813 -851 -843 -855 -848 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -733 -813 -851 -843 -855 -848 0 0   EBIT / employee   -803 -883 -921 -913 -925 -951 0 0   Net earnings / employee   184 113 86 61 77 108 0 0